C4 Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
C4 Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • C4 Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.35 USD/shares, a 36.4% increase year-over-year.
  • C4 Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.7 USD/shares, a 38.2% increase year-over-year.
  • C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.67 USD/shares, a 1.91% decline from 2022.
  • C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.62 USD/shares, a 44% decline from 2021.
  • C4 Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.82 USD/shares, a 68.8% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 $0 -1.91% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$3 -$1 -44% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$2 +$4.01 +68.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 -$6 +$25.20 +81.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$31 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.